| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-08 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0003 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.18 | 0.0006 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |